| COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review B Bikdeli, MV Madhavan, D Jimenez, T Chuich, I Dreyfus, E Driggin, ... Journal of the American college of cardiology 75 (23), 2950-2973, 2020 | 3444 | 2020 |
| National trends in ambulatory oral anticoagulant use GD Barnes, E Lucas, GC Alexander, ZD Goldberger The American journal of medicine 128 (12), 1300-1305. e2, 2015 | 640 | 2015 |
| Thromboembolism and anticoagulant therapy during the COVID-19 pandemic: interim clinical guidance from the anticoagulation forum GD Barnes, A Burnett, A Allen, M Blumenstein, NP Clark, A Cuker, ... Journal of thrombosis and thrombolysis 50, 72-81, 2020 | 594 | 2020 |
| Endorsed by the ISTH, NATF, ESVM, and the IUA, Supported by the ESC Working Group on Pulmonary Circulation and Right Ventricular Function. COVID-19 and thrombotic or … B Bikdeli, MV Madhavan, D Jimenez, T Chuich, I Dreyfus, E Driggin, ... J Am Coll Cardiol 75 (23), 2950-2973, 2020 | 412 | 2020 |
| Interventional therapies for acute pulmonary embolism: current status and principles for the development of novel evidence: a scientific statement from the American Heart … J Giri, AK Sista, I Weinberg, C Kearon, DJ Kumbhani, ND Desai, G Piazza, ... Circulation 140 (20), e774-e801, 2019 | 371 | 2019 |
| Pharmacological agents targeting thromboinflammation in COVID-19: review and implications for future research B Bikdeli, MV Madhavan, A Gupta, D Jimenez, JR Burton, ... Thrombosis and haemostasis 120 (07), 1004-1024, 2020 | 298 | 2020 |
| Prevalence of and factors associated with patient nondisclosure of medically relevant information to clinicians AG Levy, AM Scherer, BJ Zikmund-Fisher, K Larkin, GD Barnes, ... JAMA network open 1 (7), e185293-e185293, 2018 | 189 | 2018 |
| Recommendation on the nomenclature for oral anticoagulants: communication from the SSC of the ISTH GD Barnes, W Ageno, J Ansell, S Kaatz Journal of Thrombosis and Haemostasis 13 (6), 1154-1156, 2015 | 174 | 2015 |
| Society of Interventional Radiology clinical practice guideline for inferior vena cava filters in the treatment of patients with venous thromboembolic disease: developed in … JA Kaufman, GD Barnes, RA Chaer, J Cuschieri, RT Eberhardt, ... Journal of vascular and interventional radiology 31 (10), 1529-1544, 2020 | 156 | 2020 |
| Stroke and thromboembolism prevention in atrial fibrillation S Jame, G Barnes Heart 106 (1), 10-17, 2020 | 149 | 2020 |
| Practical diagnosis and treatment of suspected venous thromboembolism during COVID-19 pandemic AT Obi, GD Barnes, TW Wakefield, S Brown, JL Eliason, E Arndt, ... Journal of Vascular Surgery: Venous and Lymphatic Disorders 8 (4), 526-534, 2020 | 120 | 2020 |
| Reimagining anticoagulation clinics in the era of direct oral anticoagulants GD Barnes, BK Nallamothu, AE Sales, JB Froehlich Circulation: Cardiovascular Quality and Outcomes 9 (2), 182-185, 2016 | 87 | 2016 |
| The real world use of combined P-glycoprotein and moderate CYP3A4 inhibitors with rivaroxaban or apixaban increases bleeding S Hanigan, J Das, K Pogue, GD Barnes, MP Dorsch Journal of thrombosis and thrombolysis 49, 636-643, 2020 | 86 | 2020 |
| Venous thrombosis epidemiology, pathophysiology, and anticoagulant therapies and trials in severe acute respiratory syndrome coronavirus 2 infection AT Obi, GD Barnes, LM Napolitano, PK Henke, TW Wakefield Journal of Vascular Surgery: Venous and Lymphatic Disorders 9 (1), 23-35, 2021 | 84 | 2021 |
| Global COVID-19 thrombosis collaborative group, endorsed by the ISTH, NATF, ESVM, and the IUA, supported by the ESC working group on pulmonary circulation and right ventricular … B Bikdeli, MV Madhavan, D Jimenez, T Chuich, I Dreyfus, E Driggin, ... J Am Coll Cardiol 75 (23), 2950-2973, 2020 | 78 | 2020 |
| Diversity in the pulmonary embolism response team model: an organizational survey of the national PERT consortium members GD Barnes, C Kabrhel, DM Courtney, S Naydenov, T Wood, R Rosovsky, ... Chest 150 (6), 1414-1417, 2016 | 75 | 2016 |
| A multidisciplinary pulmonary embolism response team (PERT)—experience from a national multicenter consortium J Schultz, N Giordano, H Zheng, BA Parry, GD Barnes, GA Heresi, ... Pulmonary Circulation 9 (3), 2045894018824563, 2019 | 67 | 2019 |
| Current and emerging direct oral anticoagulants: state-of-the-art G Lippi, R Gosselin, EJ Favaloro Seminars in thrombosis and hemostasis 45 (05), 490-501, 2019 | 62 | 2019 |
| Risk factors for intracranial haemorrhage in patients with pulmonary embolism treated with thrombolytic therapy Development of the PE-CH Score S Chatterjee, I Weinberg, RW Yeh, A Chakraborty, P Sardar, ... Thrombosis and Haemostasis 117 (02), 246-251, 2017 | 62 | 2017 |
| Trends in venous thromboembolism anticoagulation in patients hospitalized with COVID-19 VM Vaughn, M Yost, C Abshire, SA Flanders, D Paje, P Grant, S Kaatz, ... JAMA network open 4 (6), e2111788-e2111788, 2021 | 56 | 2021 |
Anne SalesUniversity of Missouri and VA Ann Arbor Healthcare SystemDirección de correo verificada de missouri.edu
